Brief: Fusion Antibodies Says FY Revenue Down 40% To 2.9 Mln Stg
Sept 29 (Reuters) - Fusion Antibodies PLC FAB.L :
* FY REVENUE DOWN (NOT ROSE) 40 PERCENT TO 2.9 MILLION STG
Source text for Eikon: ID:
Further company coverage: FAB.L
(Reuters.Briefs@thomsonreuters.com)
Recent news on Fusion Antibodies
See all newsBrief: Fusion Antibodies Announces New TGE And Cryoem Project With US Pharma Client
Fusion Antibodies - Contract win
Fusion Antibodies - AGM statement H1 trading and research update
RCS - Fusion Antibodies - Launch of new customer-focused website
Fusion Antibodies - Posting of Annual Report & Notice of AGM